Top Markets
Coin of the day
Mithra Pharmaceuticals S.A. Mithra Pharmaceuticals S.A.

Mithra Pharmaceuticals S.A.

MITRA
Rangering i aksjer #30365
Mithra Pharmaceuticals SA, established in 1999 and headquartered in Liège,... Mithra Pharmaceuticals SA, established in 1999 and headquartered in Liège, Belgium, specializes in the creation, production, and worldwide commercialization of advanced therapeutic solutions. The company's core focus areas include contraception, the management of menopause, and treatments for hormone-dependent cancers. Its robust development pipeline features Estelle, a combined oral contraceptive that has successfully concluded Phase III clinical trials, and Donesta, an estetrol-based oral hormone treatment currently undergoing Phase III development for menopausal symptoms. Mithra's product portfolio also encompasses Myring, a hormonal contraceptive vaginal ring; Tibelia, a therapy designed to address both menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant targeting prostate and breast cancers, as well as various benign gynecological conditions. Furthermore, the company markets NEXTSTELLIS, an established oral contraceptive pill. Their offerings span diverse pharmaceutical formats, including polymeric devices, implants, sterile injectable medications, and hormonal tablets.
Aksjekurs
$0.25620952
Sist synkronisert: 2024-07-23
Markedsverdi
$17.14M
Endring (1 dag)
10.83%
Endring (1 år)
0.00%
Land
BE
Handel Mithra Pharmaceuticals S.A. (MITRA)

Kategori

Aksjeprishistorikk for Mithra Pharmaceuticals S.A. (MITRA)
Høyeste sluttskurs: $0.26 den 2024-07-01

Laveste sluttskurs: $13.31 den 2015-06-01
Aksjeprishistorikk for Mithra Pharmaceuticals S.A. fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 -79.92%
2023 -68.31%
2022 -82.82%
2021 -7.44%
2020 -13.95%
2019 18.19%
2018 100.30%
2017 32.01%
2016 -15.12%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$171.67 -
DE
$162.21 25.48%
DE
$37.44 22.48%
JP
$220.57 31.75%
CH
$20.69 10.80%
IN